The patients’ perspective on multimorbidity and polypharmacy and how do we accommodate it in the healthcare system.

Autor: Bissenbakker KH; Forskningsenheden for Almen Praksis, Center for Almen Medicin, Institut for Folkevidenskab, Københavns Universitet., Almarsdóttir AB; Samfundsfarmaci og Klinisk Farmaci, Institut for Farmaci, Københavns Universitet., Møller A; Forskningsenheden for Almen Praksis, Center for Almen Medicin, Institut for Folkevidenskab, Københavns Universitet., Schiøtz ML; Center for Klinisk Forskning og Forebyggelse, Københavns Universitetshospital - Bispebjerg og Frederiksberg Hospital.
Jazyk: dánština
Zdroj: Ugeskrift for laeger [Ugeskr Laeger] 2023 Oct 16; Vol. 185 (42).
Abstrakt: Patients living with multimorbidity, and polypharmacy can have difficulties handling the treatment burden they face daily. They often experience disjointed treatment courses and demand a more holistic approach to their multimorbidity and to be involved in decisions about their treatments. In the healthcare system, there are examples of new initiatives that go beyond the classic diagnostic silo thinking. However, this review finds that further development of new structures, approaches, and collaboration models in the healthcare system, as well as research, is still necessary to meet the needs of these patients.
(Published under Open Access CC-BY-NC-BD 4.0. https://creativecommons.org/licenses/by-nc-nd/4.0/.)
Databáze: MEDLINE